H.R. 1806: Triple-Negative Breast Cancer Research and Education Act of 2025

This bill is known as the Triple-Negative Breast Cancer Research and Education Act of 2025. It aims to enhance research, education, and awareness related to triple-negative breast cancer, which is a particularly aggressive form of breast cancer. The key components of this legislation include:

Research Enhancements

The bill mandates the Director of the National Institutes of Health (NIH) to:

• Expand and Intensify Research: Coordinate programs related to triple-negative breast cancer to boost research efforts.
• Coordinate Activities: Ensure that different institutes and centers within the NIH collaborate effectively on triple-negative breast cancer research.
• Funding for Research: Allocate necessary funding from 2026 to 2031 to support these research efforts.

Public Education Initiatives

The bill assigns the Secretary of Health and Human Services to:

• Develop Educational Programs: Create and spread information about triple-negative breast cancer to the general public, focusing on:
• The rates of occurrence and commonality of this type of cancer.
• The higher risks faced by minority women regarding this cancer.
• Treatment options available for those diagnosed with symptomatic triple-negative breast cancer.
• Information Dissemination: Share educational materials directly or through partnerships with various organizations, including nonprofits, media outlets, and educational institutions.
• Funding for Education: Ensure funding is available from 2026 to 2031 for carrying out these educational activities.

Information for Healthcare Providers

The bill requires the Secretary of Health and Human Services to:

• Inform Healthcare Providers: Develop and distribute information about triple-negative breast cancer to healthcare professionals to keep them updated on:
• The increased risk of triple-negative breast cancer among minority women.
• The various treatment options available for patients diagnosed with the disease.
• Authorization of Funds: Allocate necessary funds for these initiatives from 2026 through 2031.

Focus on Minority Women

The bill highlights the importance of addressing the heightened risk of triple-negative breast cancer among minority women, defined as those belonging to racial and ethnic minority groups, and emphasizes the need for specific research and educational efforts targeted at this population.

Overall Purpose

The overarching intent of the legislation is to improve outcomes for women affected by triple-negative breast cancer through increased understanding, early detection, and informed treatment options.

Relevant Companies

None found